1. Home
  2. WVE vs EVLV Comparison

WVE vs EVLV Comparison

Compare WVE & EVLV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Wave Life Sciences Ltd.

WVE

Wave Life Sciences Ltd.

HOLD

Current Price

$6.27

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Logo Evolv Technologies Holdings Inc.

EVLV

Evolv Technologies Holdings Inc.

HOLD

Current Price

$6.28

Market Cap

1.2B

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
WVE
EVLV
Founded
2012
2013
Country
Singapore
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Computer peripheral equipment
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
1.2B
IPO Year
2015
N/A

Fundamental Metrics

Financial Performance
Metric
WVE
EVLV
Price
$6.27
$6.28
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
16
4
Target Price
$29.81
$9.13
AVG Volume (30 Days)
3.3M
2.6M
Earning Date
04-28-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$3,704,000.00
N/A
Revenue This Year
N/A
$21.67
Revenue Next Year
$85.67
$19.50
P/E Ratio
N/A
N/A
Revenue Growth
149.43
N/A
52 Week Low
$5.02
$4.61
52 Week High
$21.73
$8.90

Technical Indicators

Market Signals
Indicator
WVE
EVLV
Relative Strength Index (RSI) 53.10 56.81
Support Level $6.02 $5.40
Resistance Level $6.31 $6.34
Average True Range (ATR) 0.29 0.31
MACD 0.07 0.08
Stochastic Oscillator 89.52 74.00

Price Performance

Historical Comparison
WVE
EVLV

About WVE Wave Life Sciences Ltd.

WAVE Life Sciences Ltd is a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines also known as oligonucleotides, targeting ribonucleic acid (RNA), to transform human health. RNA medicines platform, PRISM, combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. Its toolkit of RNA-targeting modalities includes RNA editing, antisense silencing, and RNA interference, providing capabilities for designing and sustainably delivering candidates that optimally address disease biology. Its programs are for rare and prevalent diseases, including alpha-1 antitrypsin deficiency, obesity, Duchenne muscular dystrophy, and Huntington's disease.

About EVLV Evolv Technologies Holdings Inc.

Evolv Technologies Holdings Inc offers an AI-based touchless security screening. Its touchless security screening systems use artificial intelligence software, cloud services, and sensors to reliably detect dangerous weapons while ignoring harmless items like cell phones, laptops, and keys. It offers products for purchase under a multi-year security-as-a-service subscription pricing model that delivers ongoing value to customers, generates predictable revenue, and creates expansion and upsell opportunities. The firm operates in a single segment that develops, manufactures, markets, and sells security screening products and specific services. Its products are used in different industries such as casinos, industrial workplaces, schools, and ticketed venues.

Share on Social Networks: